Session Title: Connecting the Dots: Neurodevelopmental Monitoring, Early Developmental Clinics, and Cerebral Palsy Diagnosis
Session Leader: Brooke Kimbrell, MD MSE
Session Co-leaders: Lisa Letzkus; Patrick McPhee
Session Description:
Central nervous system injury in early life is strongly associated with a wide range of neurodevelopmental disorders, including developmental delay, intellectual disability, specific learning disorders, ADHD, mood disorders, and other psychiatric conditions. Individuals with cerebral palsy (CP) carry the highest risk of co-occurring neurodevelopmental disorders, yet current CP guidelines lack specific recommendations for standardized cognitive screening timelines and tools across the lifespan. At the same time, as early detection of CP becomes more standardized, the functional boundary between Early Developmental Clinics (EDCs) and CP clinics is increasingly blurred.
EDCs are structured to provide surveillance, risk stratification, standardized neurologic assessment, and early referral for infants at high risk of disability. CP clinics, in contrast, focus on diagnosis confirmation, tone and movement disorder management, orthopedic surveillance, spasticity treatment, equipment planning, and long-term functional optimization. This interactive session will explore how goals shift—and overlap—across these care models, and how neurodevelopmental monitoring from NICU follow-up through childhood and adulthood can be better integrated.
We will present findings from a CPRN-wide survey describing current cognitive and psychiatric assessment practices in preschool, school-age, and adult CP populations, highlighting practice variation and gaps in care. Participants will examine key transition triggers (e.g., abnormal General Movements Assessment, concerning HINE scores, neuroimaging findings, persistent motor asymmetry) and discuss optimal timing for transition between clinics. The session will culminate in development of a consensus-based transition checklist to clarify roles, align surveillance and diagnostic pathways, and promote coordinated, family-centered neurodevelopmental care across the continuum.
Session Objectives: • Describe current practices in neurodevelopmental surveillance and assessment for individuals with CP from infancy through adulthood, including findings from the CPRN network survey.
• Define the distinct and overlapping roles of Early Developmental Clinics and CP clinics, including key transition triggers and optimal timing for transfer of care
• Explain how co-occurring neurodevelopmental and psychological disorders influence motor, functional, and long-term outcomes in individuals with CP.
• Identify opportunities to standardize cognitive and psychological screening, including refinement and expansion of CPRN data elements across the lifespan.
• Develop a practical, family-centered transition framework and checklist to guide coordinated implementation of CP-specific care pathways across clinic settings.
Who Should Attend: This session is designed for individuals with lived experience, developmental-behavioral pediatricians, pediatric neurologists, neonatologists, nurse practitioners, therapists, care coordinators, NICU follow-up providers, quality improvement leaders, administrators, and researchers involved in high-risk infant follow-up and CP care. It is particularly relevant for clinicians and investigators seeking to reduce practice variation, improve coordinated neurodevelopmental monitoring, and better understand differences in treatment response and long-term outcomes.